GE HealthCare Technologies (GEHC) Stock Forecast & Price Target

$66.63 +0.25 (+0.38%)

Closing price 09/25/2026 04:00 PM Eastern

Extended Trading

$65.92 -0.71 (-1.07%)

As of 09/25/2026 07:55 PM Eastern

Compare

GE HealthCare Technologies - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Moderate Buy

Based on 22 Analyst Ratings

Sell
0

Hold
11

Buy
11

Based on 22 Wall Street analysts who have issued ratings for GE HealthCare Technologies in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 22 analysts, 11 have given a hold rating, and 11 have given a buy rating for GEHC.

Consensus Price Target

$78.39
17.65% Upside

According to the 22 analysts' twelve-month price targets for GE HealthCare Technologies, the average price target is $78.39. The highest price target for GEHC is $98.00, while the lowest price target for GEHC is $14.00. The average price target represents a forecasted upside of 17.65% from the current price of $66.63.

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Get the Latest News and Ratings for GEHC and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for GE HealthCare Technologies and its competitors.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

GEHC Analyst Ratings Over Time

Type	Current Forecast 9/27/25 to 9/27/26	1 Month Ago 8/28/25 to 8/28/26	3 Months Ago 6/29/25 to 6/29/26	1 Year Ago 9/27/24 to 9/27/25
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	1 Strong Buy rating(s)
Buy	11 Buy rating(s)	10 Buy rating(s)	10 Buy rating(s)	8 Buy rating(s)
Hold	11 Hold rating(s)	11 Hold rating(s)	9 Hold rating(s)	3 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$78.39	$77.73	$80.20	$88.40
Forecasted Upside	17.65% Upside	8.38% Upside	23.29% Upside	22.00% Upside
Consensus Rating	Moderate Buy	Hold	Moderate Buy	Moderate Buy

GEHC Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

GEHC Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

GE HealthCare Technologies Stock vs. The Competition

Type	GE HealthCare Technologies	Healthcare Companies	Broader Market
Consensus Rating Score	2.50	2.31	2.53
Consensus Rating	Moderate Buy	Hold	Moderate Buy
Predicted Upside	17.65% Upside	764.10% Upside	19.20% Upside
News Sentiment Rating	Positive News See Recent GEHC News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export

Date	Brokerage	Analyst	Action	Rating	Price Target	Report Date Upside/Downside
9/22/2026	Needham & Company LLC 4 of 5 stars	David Saxon 2 of 5 stars	Initiated Coverage	Buy	$93.00	+43.50%
9/17/2026	BTIG Research 3 of 5 stars	Ryan Zimmerman 3 of 5 stars	Reiterated Rating	Buy	$79.00	+24.43%
8/12/2026	Weiss Ratings 5 of 5 stars		Reiterated Rating	Hold (C-)
8/11/2026	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Upgrade	Strong Sell ➝ Hold
7/31/2026	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Graham Doyle Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Neutral	$67.00 ➝ $73.00	+7.32%
7/30/2026	Evercore Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Reiterated Rating	Outperform	$84.00	+21.58%
7/30/2026	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Suraj Kalia Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Outperform
7/30/2026	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Joanne Wuensch Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Neutral	$69.00 ➝ $75.00	+4.31%
7/30/2026	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Larry Biegelsen Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Overweight	$75.00 ➝ $85.00	+22.84%
7/29/2026	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jason Bednar Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Buy
Get the Latest News and Ratings for GEHC and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for GE HealthCare Technologies and its competitors with MarketBeat's FREE daily newsletter.
7/17/2026	Hovde Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Initiated Coverage	Market Perform	$14.00	-77.87%
7/8/2026	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Initiated Coverage	Market Perform	$70.00	+8.23%
6/23/2026	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Shagun Singh Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	Outperform	$80.00	+31.93%
6/8/2026	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	David Roman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Neutral
5/19/2026	Argus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Lower Target	Buy	$95.00 ➝ $80.00	+28.92%
5/1/2026	BNP Paribas Exane Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Lower Target		$95.00 ➝ $88.00	+44.24%
4/30/2026	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Matt Miksic Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Equal Weight	$87.00 ➝ $78.00	+31.11%
4/30/2026	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Anthony Petrone Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target		$90.00 ➝ $80.00	+32.31%
4/30/2026	HSBC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Lower Target		$100.00 ➝ $90.00	+47.52%
4/30/2026	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Lower Target		$105.00 ➝ $90.00	+47.52%
4/30/2026	Rothschild & Co Redburn Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Lower Target		$110.00 ➝ $98.00	+60.63%
4/30/2026	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Robbie Marcus Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Neutral	$80.00 ➝ $65.00	+6.84%
4/29/2026	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Set Target		$80.00	+34.24%
2/4/2026	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Patrick Wood Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Equal Weight	$80.00 ➝ $85.00	+2.93%
1/5/2026	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Craig Bijou Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Neutral	$82.00 ➝ $92.00	+11.08%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Sunday at 01:04 PM ET.

Should I Buy GE HealthCare Technologies Stock? GEHC Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Thursday, September 24, 2026. Please send any questions or comments about these GE HealthCare Technologies pros and cons to contact@marketbeat.com.

GE HealthCare Technologies
Bull Case

Here are some ways that investors could benefit from investing in GE HealthCare Technologies Inc.:

The stock is currently trading at $66.38, which is significantly below the average analyst price target of $77.73, suggesting potential upside as the consensus rating remains a Hold with several analysts issuing Buy ratings.
GE HealthCare Technologies Inc. recently increased its quarterly dividend by 14.3% to $0.04 per share, signaling confidence in its financial stability and ability to return capital to shareholders while maintaining a low payout ratio of 3.0%.
The company demonstrated strong financial performance in the most recent quarter, beating consensus estimates with earnings per share of $1.13 compared to the expected $1.04, and achieving revenue of $5.29 billion, which exceeded the $5.26 billion forecast.
Institutional investors are showing renewed interest, with Andra AP fonden increasing its holdings by 8,646.2% in the second quarter and Needham & Company LLC initiating coverage with a Buy rating and a $93.00 price target, indicating a potential turnaround.
The company is expanding its digital health capabilities by rolling out AI software for predicting care bottlenecks, which could enhance operational efficiency and create new revenue streams in the healthcare technology sector.

GE HealthCare Technologies
Bear Case

Investors should be bearish about investing in GE HealthCare Technologies Inc. for these reasons:

The stock has underperformed the market, trading down 28% from its 52-week high of $89.77, and is currently below its 50-day and 200-day simple moving averages, indicating a bearish technical trend.
Short interest in GE HealthCare Technologies Inc. has increased significantly, with 16.9 million shares shorted as of September 2026, representing a 3.76% short percentage of the float, which suggests bearish sentiment among traders.
The company is facing a securities fraud investigation, which could lead to legal costs, reputational damage, and potential financial liabilities that may impact future earnings and stock price.
The dividend yield is very low at 0.21%, offering minimal income for investors seeking yield, and the payout ratio of 3.0% indicates that the company is retaining most of its earnings rather than distributing them.
The company's debt-to-equity ratio is 0.92, which is relatively high for a healthcare technology firm, and the current ratio of 1.26 suggests limited liquidity to cover short-term obligations, potentially increasing financial risk.

GEHC Forecast - Frequently Asked Questions

According to the research reports of 22 Wall Street equities research analysts, the average twelve-month stock price forecast for GE HealthCare Technologies is $78.39, with a high forecast of $98.00 and a low forecast of $14.00.

22 Wall Street analysts have issued "buy," "hold," and "sell" ratings for GE HealthCare Technologies in the last twelve months. There are currently 11 hold ratings and 11 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" GEHC shares.

According to analysts, GE HealthCare Technologies's stock has a predicted upside of 17.65% based on their 12-month stock forecasts.

Over the previous 90 days, GE HealthCare Technologies's stock had 2 upgrades and 1 downgrade by analysts.

GE HealthCare Technologies has been rated by research analysts at BMO Capital Markets, BTIG Research, Citigroup, Evercore, Hovde Group, Needham & Company LLC, Oppenheimer, Piper Sandler, UBS Group, Weiss Ratings, Wells Fargo & Company, and Zacks Research in the past 90 days.

Analysts like GE HealthCare Technologies more than other "healthcare" companies. The consensus rating for GE HealthCare Technologies is Moderate Buy while the average consensus rating for "healthcare" companies is Hold. Learn more on how GEHC compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With GE HealthCare Technologies Recommendations

MarketBeat monitors more than a dozen sources for GE HealthCare Technologies analyst ratings, with the most recent rating issued on 9/22/2026.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

GE HealthCare Technologies (GEHC) Stock Forecast & Price Target

GE HealthCare Technologies - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Consensus Price Target

GEHC Analyst Ratings Over Time

GEHC Analyst Recommendations By Month

GEHC Price Targets by Month

GE HealthCare Technologies Stock vs. The Competition

Recent Analyst Forecasts and Stock Ratings

Should I Buy GE HealthCare Technologies Stock? GEHC Pros and Cons Explained

GE HealthCare Technologies
Bull Case

GE HealthCare Technologies
Bear Case

GEHC Forecast - Frequently Asked Questions

Stock Forecasts and Research Tools

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With GE HealthCare Technologies Recommendations

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

GE HealthCare Technologies (GEHC) Stock Forecast & Price Target

GE HealthCare Technologies - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Consensus Price Target

GEHC Analyst Ratings Over Time

GEHC Analyst Recommendations By Month

GEHC Price Targets by Month

GE HealthCare Technologies Stock vs. The Competition

Recent Analyst Forecasts and Stock Ratings

Should I Buy GE HealthCare Technologies Stock? GEHC Pros and Cons Explained

GE HealthCare Technologies Bull Case

GE HealthCare Technologies Bear Case

GEHC Forecast - Frequently Asked Questions

What is GE HealthCare Technologies' forecast for 2026?

Should I buy or sell GE HealthCare Technologies stock right now?

Does GE HealthCare Technologies's stock price have much upside?

Has GE HealthCare Technologies been upgraded or downgraded by Wall Street analysts recently?

What analysts cover GE HealthCare Technologies?

Do Wall Street analysts like GE HealthCare Technologies more than its competitors?

Stock Forecasts and Research Tools

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With GE HealthCare Technologies Recommendations

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

GE HealthCare Technologies
Bull Case

GE HealthCare Technologies
Bear Case